[Sponsored] Facing a loss of patients and revenue to outside referrals, Hancock Health joined the Mayo Clinic Care Network and achieved a dramatic turnaround. The post Hancock Health’s $1.1M Turnaround appeared first on MedCity News.
It isn’t easy to promote moderation and financial discipline from the bowels of a casino. But that’s what Massachusetts state workers try to do every day, amid the clanging bells and flashing lights of the slot machines. At the MGM Springfield in western Massachusetts, workers wearing green polos stand outside their small office, right off…
SARASOTA, Fla. — Florida plans to end nearly a half-century of required childhood immunizations against diseases that have killed and maimed millions of children. Many critics of the decision, including doctors, are afraid to speak up against it. With the support of Republican Gov. Ron DeSantis, Surgeon General Joseph Ladapo on Sept. 3 announced his…
By MIKE MAGEE With the announcement of the 2025 Nobel Prize in Physiology or Medicine last week, the American Association of Immunologists (AAI) took an understandable victory lap, stating: “This Nobel Prize demonstrates how immunology is central to medicine and human health. The ability to harness, modulate, or restrain immune responses holds promise across a…
At the HLTH conference in Las Vegas, Colton Underwood and fertility experts highlighted the need to break the stigma around male infertility, urging greater awareness, testing and support to recognize it as a men’s health issue as much as a women’s one. The post How the Stigma Around Male Infertility Can Be Reduced appeared first…
Town Hall Ventures launched its fourth fund, targeting $440 million to back startups using AI to improve healthcare access and outcomes for underserved populations. The post Inside Town Hall Ventures’ New $440M Fund appeared first on MedCity News.
Flagship Pioneering’s newest startup is Expedition Medicines, a company whose artificial intelligence-driven technology platform analyzes the human proteome to learn the chemistry of binding small molecules to protein targets long considered “undruggable.” Expedition already has a cancer drug R&D alliance with Pfizer. The post Startup Expedition Medicines Launches to Learn Nature’s Rules for Binding Elusive…
With closures accelerating and communities already losing access to care, the countdown to FY 2026 is not far off. States, providers and technology partners that act now will define the future of rural health for decades; those that delay may leave billions untapped and lives at risk. The post Rural Health Transformation Program: What States…
Site networks can play a pivotal role in aligning sponsors, sites, and investigators toward shared goals in oncology clinical trials, but they are not one-size-fits-all. Sponsors must carefully vet site networks to validate that they will deliver strategic value for each individual study. The post Redefining Clinical Oncology Trials: How Agile Site Networks Accelerate Novel Cancer…
With science funding catapulted into the cultural conversation more than ever in the last year, it faces a critical inflection point. There is an opportunity to design a path forward that builds stability in the short term and opens doors in the long term for foundational and transformational science and technology solutions that will benefit…